A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/1997
11/27/1997	WO1997044461A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
11/27/1997	WO1997044453A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
11/27/1997	WO1997044350A1 Inhibitors of protein farnesyl transferase
11/27/1997	WO1997044339A1 Antagonists of gonadotropin releasing hormone
11/27/1997	WO1997044336A1 Conjugates of cis-docosahexaenoic acid and paclitaxel
11/27/1997	WO1997044063A2 Dha-pharmaceutical agent conjugates
11/27/1997	WO1997044054A2 Type-2 chemokine binding proteins and methods of use therefor
11/27/1997	WO1997044053A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
11/27/1997	WO1997044044A1 Therapeutic uses for an aminosterol compound
11/27/1997	WO1997044043A1 Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-fudca)
11/27/1997	WO1997044037A1 Antagonists of gonadotropin releasing hormone
11/27/1997	WO1997044026A1 Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
11/27/1997	WO1997044000A2 Dna-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
11/27/1997	WO1997039102A3 Secreted proteins
11/27/1997	WO1997038665A3 Inhibitors of farnesyl-protein transferase
11/27/1997	DE19629938C1 Monoclonal antibodies specific for mutated E-Cadherin peptide sequences
11/27/1997	CA2804657A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
11/27/1997	CA2256568A1 Type-2 chemokine binding proteins and methods of use therefor
11/27/1997	CA2255640A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
11/27/1997	CA2254769A1 Antagonists of gonadotropin releasing hormone
11/27/1997	CA2254756A1 Antagonists of gonadotropin releasing hormone
11/27/1997	CA2253934A1 Inhibitors of protein farnesyl transferase
11/26/1997	EP0808844A2 Antisense oligonucleotides complementary to the primary transcript of the human c-fes protooncogene and their use, combined with a differentiation inducer to cause apoptosis of leukemic blast cells
11/26/1997	EP0808833A2 Vitamin D3 analogs
11/26/1997	EP0808831A2 Fluorinated vitamin D3 analogs
11/26/1997	EP0808365A1 Human interleukin-1 receptor accessory protein
11/26/1997	EP0808329A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
11/26/1997	EP0808328A1 Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same
11/26/1997	EP0808323A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF
11/26/1997	EP0808322A1 RIBOZYMES WITH OPTIMIZED HYBRIDIZING ARMS, STEMS, AND LOOPS, tRNA EMBEDDED RIBOZYMES AND COMPOSITIONS THEREOF
11/26/1997	EP0808321A1 InK4c-p18 AND InK4D-p19, INHIBITORS OF CYCLIN-DEPEDENT KINASES CDK4 AND CDK6, AND USES THEREOF
11/26/1997	EP0808319A1 Epipodophyllotoxin triaryloxyacetyl derivatives, method for preparing same, and use of said derivatives as cancer drugs
11/26/1997	EP0808309A1 Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors
11/26/1997	EP0808169A1 Programmed cell death genes and proteins
11/26/1997	EP0719271B1 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
11/26/1997	EP0691977B1 Oligonucleotides with amide linkages replacing phosphodiester linkages
11/26/1997	EP0662130B1 A method of producing hepatocyte growth factor and a cell line
11/26/1997	EP0580829B1 Bacterial protein extract, process for preparing the same and pharmaceutical composition containing said extract
11/26/1997	CN1166170A Novel taxoids, preparation thereof, and pharmaceutical compsns. containing same
11/26/1997	CN1165817A New inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them
11/26/1997	CN1165676A Instant powder for nourishing blood and its prepn. method
11/26/1997	CN1165651A Use of (E)-1£4'-(2-alkylaminoethioxy) phenyl\|-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions
11/26/1997	CN1036532C Process for preparing non-glycosylated recombining human IL2 in reduced form
11/25/1997	US5691382 Enzyme inhibitors for cardiovascular disorders
11/25/1997	US5691381 Antagonist of tumor necrosis factor, antiinflammatory agent, antiarthritic agent
11/25/1997	US5691374 Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors
11/25/1997	US5691371 Antitumor and -carcinogenic agents; prodrugs bioreduced to release a cytotoxin, a mechlorethamine derivative; water soluble
11/25/1997	US5691355 Syneristic mixture; therapy for breast cancer
11/25/1997	US5691353 Method of inhibiting aortal smooth muscle cell proliferation using naphthyl compounds
11/25/1997	US5691319 Anticarcinogenic agents
11/25/1997	US5691317 Antisense oligonucleotides of human regulatory subunit RI-alpha of cAMP dependent protein kinases for the treatment of cancer
11/25/1997	US5691311 Methods for coating invasive devices with inhibitors of thrombin
11/25/1997	US5690935 Biotherapy of cancer by targeting TP-3/P80
11/25/1997	US5690930 Anticarcinogenic and antipsoriasis agents; viricides
11/25/1997	US5690929 Use of methioninase and chemotherapy agents in chemotherapy
11/25/1997	US5690928 Administering transforming growth factor
11/25/1997	CA2099865C Hepatic growth factor receptor is the met proto-oncogene
11/25/1997	CA2077598C Alkoxy substituted taxanes and pharmaceutical compositions containing them
11/25/1997	CA1339557C Cell sorting technique and applications thereof
11/20/1997	WO1997043311A1 Anticoagulant peptide fragments derived from apolipoprotein b-100
11/20/1997	WO1997043299A1 Alkylated nucleoside-3'-phosphates, process for producing them and their use
11/20/1997	WO1997043291A1 Taxane derivatives, the preparation thereof and formulations containing them
11/20/1997	WO1997043290A1 Camptothecin-skeleton compounds isolated from mappia foetida and the use thereof as syntones for novel medicaments as well as therapeutical agents
11/20/1997	WO1997043278A1 Somatostatin agonists and antagonists
11/20/1997	WO1997043272A2 Benzofurans and benzopyrans as chronobiological agents
11/20/1997	WO1997043268A1 8-hydrocarbyl substituted benzodizocine derivatives, their preparation and their use as protein kinase c (=pkc) modulators
11/20/1997	WO1997043258A1 Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
11/20/1997	WO1997043245A1 Inhibition of matrix metalloproteases by acetylene containing compounds
11/20/1997	WO1997043240A1 INHIBITION OF MATRIX METALLOPROTEASES BY 2-(φ-AROYLALKYL)-4-BIARYL-OXOBUTYRIC ACIDS
11/20/1997	WO1997043239A1 Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids
11/20/1997	WO1997043238A1 Substituted oxobutyric acids as matrix metalloprotease inhibitors
11/20/1997	WO1997043237A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
11/20/1997	WO1997042973A1 Method and composition for reconforming multi-epitopic antigens to initiate an immune response
11/20/1997	WO1997042968A2 Administration of histamine for therapeutic purposes
11/20/1997	WO1997042962A1 Formulation for use in the prevention of pathogen induced diseases including hiv and hsv
11/20/1997	WO1997042948A1 7-o-methoxymethyl paclitaxel
11/20/1997	WO1997042939A1 Liposomal antineoplaston therapies with markedly improved antineoplastic activity
11/20/1997	WO1997038664A3 A method of treating cancer
11/20/1997	WO1997035994A3 Cytochrome p450 transducing retroviral vectors
11/20/1997	WO1997026017A3 Perfluoroalkyl-containing metal complexes and their use in nmr diagnostics
11/20/1997	CA2253802A1 Benzofurans and benzopyrans as chronobiological agents
11/20/1997	CA2253652A1 Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
11/20/1997	CA2253602A1 Method and composition for reconforming multi-epitopic antigens to initiate an immune response
11/20/1997	CA2253463A1 8-hydrocarbyl substituted benzodizocine derivatives, their preparation and their use as protein kinase c (=pkc) modulators
11/20/1997	CA2253443A1 7-o-methoxymethyl paclitaxel
11/20/1997	CA2253365A1 Administration of histamine for therapeutic purposes
11/19/1997	EP0807683A2 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
11/19/1997	EP0807624A2 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
11/19/1997	EP0807185A1 Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus
11/19/1997	EP0807183A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
11/19/1997	EP0807176A2 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma
11/19/1997	EP0807174A1 Modified ligands for receptor tyrosine kinases
11/19/1997	EP0807125A2 Monoclonal antibodies anti-cd6 and their uses
11/19/1997	EP0807124A1 Flt4 receptor tyrosine kinase and its use in diagnosis and therapy
11/19/1997	EP0807121A1 New pharmaceuticals for modulating hormone responsiveness
11/19/1997	EP0807114A1 Bridged indoles as matrix metalloprotease inhibitors
11/19/1997	EP0807111A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
11/19/1997	EP0806964A1 Chemical compounds
11/19/1997	EP0806963A1 Carcinoma treatment
11/19/1997	EP0806960A1 Extracts of shark cartilage, process of production and uses thereof

1 ... 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 ... 2211